Kazuhiro Chiba
Corporate Officer/Principal presso Tokyo University of Agriculture & Technology
Profilo
Kazuhiro Chiba founded Jitsubo Co., Ltd.
in 2005, where he worked as Director & Chief Scientific Officer.
Dr. Chiba also currently works at Tokyo University of Agriculture & Technology, as Vice Dean & Professor.
Dr. Chiba also formerly worked at Kewpie Corp., as Principal.
Dr. Chiba received his graduate degree from Tokyo University of Agriculture & Technology.
Posizioni attive di Kazuhiro Chiba
| Società | Posizione | Inizio |
|---|---|---|
| Tokyo University of Agriculture & Technology | Corporate Officer/Principal | - |
Precedenti posizioni note di Kazuhiro Chiba
| Società | Posizione | Fine |
|---|---|---|
| KEWPIE CORPORATION | Corporate Officer/Principal | - |
Jitsubo Co., Ltd.
 Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Fondatore | - |
Formazione di Kazuhiro Chiba
| Tokyo University of Agriculture & Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KEWPIE CORPORATION | Consumer Non-Durables |
| Aziende private | 1 |
|---|---|
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Kazuhiro Chiba
